Regulation of Human T-Lymphotropic Virus Type I Latency and Reactivation by HBZ and Rex
Most HTLV-1-infected individuals are asymptomatic. It is thought that the proviral DNA is transcriptionally inert and HTLV-1 replicates through mitotic expansion of host cells. The evolving provirus integration patterns in HTLV-1 carriers, however, suggest new infection occurs continuously. Whether or how HTLV-1 establishes latency and reactivates is unclear. We show that HTLV-1 infection in culture can lead to two alternative outcomes — productive infection accompanied by senescence or latent infection followed by clonal expansion — based on the relative expression of regulatory proteins: Tax, Rex, and HBZ. HTLV-1 latency is established by HBZ, and reactivation is achieved by Rex through regulating nuclear export of viral mRNAs. Elucidating mechanisms underlying HTLV-1 latency and reactivation can facilitate virus control to prevent progression to disease.
Vyšlo v časopise:
Regulation of Human T-Lymphotropic Virus Type I Latency and Reactivation by HBZ and Rex. PLoS Pathog 10(4): e32767. doi:10.1371/journal.ppat.1004040
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1004040
Souhrn
Most HTLV-1-infected individuals are asymptomatic. It is thought that the proviral DNA is transcriptionally inert and HTLV-1 replicates through mitotic expansion of host cells. The evolving provirus integration patterns in HTLV-1 carriers, however, suggest new infection occurs continuously. Whether or how HTLV-1 establishes latency and reactivates is unclear. We show that HTLV-1 infection in culture can lead to two alternative outcomes — productive infection accompanied by senescence or latent infection followed by clonal expansion — based on the relative expression of regulatory proteins: Tax, Rex, and HBZ. HTLV-1 latency is established by HBZ, and reactivation is achieved by Rex through regulating nuclear export of viral mRNAs. Elucidating mechanisms underlying HTLV-1 latency and reactivation can facilitate virus control to prevent progression to disease.
Zdroje
1. GessainA, CassarO (2012) Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 3: 388.
2. TaylorGP, MatsuokaM (2005) Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24: 6047–6057.
3. MatsuokaM, JeangKT (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270–280.
4. AsquithB, HanonE, TaylorGP, BanghamCR (2000) Is human T-cell lymphotropic virus type I really silent? Philos Trans R Soc Lond B Biol Sci 355: 1013–1019.
5. UmekiK, HisadaM, MaloneyEM, HanchardB, OkayamaA (2009) Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica. Intervirology 52: 115–122.
6. HanonE, HallS, TaylorGP, SaitoM, DavisR, et al. (2000) Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386–1392.
7. JacobsonS, ShidaH, McFarlinDE, FauciAS, KoenigS (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245–248.
8. HilburnS, RowanA, DemontisMA, MacnamaraA, AsquithB, et al. (2011) In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis 203: 529–536.
9. JeangKT, GiamCZ, MajoneF, AboudM (2004) Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 279: 31991–31994.
10. ZhiH, YangL, KuoYL, HoYK, ShihHM, et al. (2011) NF-kappaB Hyper-Activation by HTLV-1 Tax Induces Cellular Senescence, but Can Be Alleviated by the Viral Anti-Sense Protein HBZ. PLoS Pathog 7: e1002025.
11. GaudrayG, GachonF, BasbousJ, Biard-PiechaczykM, DevauxC, et al. (2002) The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76: 12813–12822.
12. ZhaoT, YasunagaJ, SatouY, NakaoM, TakahashiM, et al. (2009) Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood 113: 2755–2764.
13. LiuM, YangL, ZhangL, LiuB, MerlingR, et al. (2008) Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle. J Virol 82: 8442–8455.
14. ZhangL, LiuM, MerlingR, GiamCZ (2006) Versatile reporter systems show that transactivation by human T-cell leukemia virus type 1 Tax occurs independently of chromatin remodeling factor BRG1. J Virol 80: 7459–7468.
15. KuoYL, GiamCZ (2006) Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J 25: 1741–1752.
16. KusuharaK, AndersonM, PettifordSM, GreenPL (1999) Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol 73: 8112–8119.
17. YounisI, GreenPL (2005) The human T-cell leukemia virus Rex protein. Front Biosci 10: 431–445 1539 [pii].
18. ChaturvediAK, WilsonM, Sanders-LewisKA, KatkiHA, UrquhartN, et al. (2007) Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: a report from the population-based blood donors study. Clin Infect Dis 45: 975–982.
19. LemassonI, LewisMR, PolakowskiN, HivinP, CavanaghMH, et al. (2007) Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 81: 1543–1553.
20. NicotC, DundrM, JohnsonJM, FullenJR, AlonzoN, et al. (2004) HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 10: 197–201.
21. ZhangW, NisbetJW, AlbrechtB, DingW, KashanchiF, et al. (2001) Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J Virol 75: 9885–9895.
22. AsquithB, ZhangY, MosleyAJ, de LaraCM, WallaceDL, et al. (2007) In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A 104: 8035–8040.
23. BanghamCR, OsameM (2005) Cellular immune response to HTLV-1. Oncogene 24: 6035–6046.
24. KattanT, MacnamaraA, RowanAG, NoseH, MosleyAJ, et al. (2009) The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 182: 5723–5729.
25. XueW, ZenderL, MiethingC, DickinsRA, HernandoE, et al. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656–660.
26. AdamsPD (2009) Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 36: 2–14.
27. MacnamaraA, RowanA, HilburnS, KadolskyU, FujiwaraH, et al. (2010) HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 6: e1001117.
28. GilletNA, MalaniN, MelamedA, GormleyN, CarterR, et al. (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117: 3113–3122.
29. TakedaS, MaedaM, MorikawaS, TaniguchiY, YasunagaJ, et al. (2004) Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 109: 559–567.
30. SatouY, YasunagaJ, YoshidaM, MatsuokaM (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103: 720–725.
31. SatouY, YasunagaJ, ZhaoT, YoshidaM, MiyazatoP, et al. (2011) HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 7: e1001274.
32. ArnoldJ, ZimmermanB, LiM, LairmoreMD, GreenPL (2008) Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 112: 3788–3797.
33. KamihiraS, SugaharaK, TsurudaK, MinamiS, UemuraA, et al. (2005) Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells. Clin Lab Haematol 27: 235–241.
34. LivakKJ, SchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25: 402–408.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2014 Číslo 4
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- The 2010 Cholera Outbreak in Haiti: How Science Solved a Controversy
- Coxsackievirus-Induced miR-21 Disrupts Cardiomyocyte Interactions via the Downregulation of Intercalated Disk Components
- An Overview of Respiratory Syncytial Virus
- , , , Genetic Variability: Cryptic Biological Species or Clonal Near-Clades?